Ten years after the completion of the human genome project, competition between instrument makers and attempts to capture medical value from DNA sequence data continue to make the news.

FORBES: Your Genome's On An iPhone (trying to call home...)

Back then, Celera Genomics (nyse: CRA - news - people ) and the publicly funded Human Genome Project (HGP) had yet to show off their drafts of the human DNA sequence and Celera's market cap was nearly eight times what it is now.

FORBES: DeCode's Genetic Breakthrough Barely Registers

But since the first draft sequence of the human genome was released in 2000, scientists have realized that junk DNA plays a key role in switching genes on and off.

FORBES: Magazine Article